Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Current Assets (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Current Assets for 3 consecutive years, with $314.1 million as the latest value for Q1 2026.

  • Quarterly Current Assets rose 349.2% to $314.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $314.1 million through Jan 2026, up 349.2% year-over-year, with the annual reading at $255.3 million for FY2025, 1612.81% up from the prior year.
  • Current Assets for Q1 2026 was $314.1 million at Kestra Medical Technologies, up from $195.4 million in the prior quarter.
  • The five-year high for Current Assets was $314.1 million in Q1 2026, with the low at $14.9 million in Q2 2024.
  • Average Current Assets over 3 years is $178.4 million, with a median of $208.1 million recorded in 2025.
  • The sharpest move saw Current Assets surged 1612.81% in 2025, then soared 349.2% in 2026.
  • Over 3 years, Current Assets stood at $14.9 million in 2024, then soared by 1210.89% to $195.4 million in 2025, then soared by 60.72% to $314.1 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods came in at $314.1 million, $195.4 million, and $220.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.